List of works by Bradley J. Monk

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer

scientific article published on 10 March 2015

A clinical pathway for postoperative management and early patient discharge: does it work in gynecologic oncology?

scientific article published on 2 June 2008

A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study

scientific article

A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer.

scientific article published on 23 October 2014

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer

scientific article published in November 2008

A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer

scientific article published on 08 January 2020

A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study

scientific article published on 17 July 2017

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

article

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study

scientific article

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

scientific article published on 27 January 2014

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study

scientific article

A stiff bristled, spiral-shaped ectocervical brush: a device for transepithelial tissue biopsy

scientific article published on December 2002

A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients

scientific article published on 07 October 2019

Abstract B71: Old age and chemotherapy contribute to the selection of PPM1D somatic mosaic mutations in ovarian cancer

article

Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer

scientific article published on 01 March 2005

Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma

scientific article

Adenocarcinoma of the uterine cervix: why is it different?

scientific article

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future

scientific article published on 14 November 2015

Age considerations when vaccinating against HPV.

scientific article published on May 2008

American Society of Clinical Oncology 2010 Annual Meeting update: summary of selected gynecologic cancer abstracts

scientific article published in September 2010

American Society of Clinical Oncology 2011 Annual Meeting update: summary of selected gynecologic cancer abstracts

scientific article published in August 2011

American Society of Clinical Oncology 2012 annual meeting update: summary of selected gynecologic cancer abstracts

scientific article published on 16 June 2012

An early signal of CA-125 progression for ovarian cancer patients receiving maintenance treatment after complete clinical response to primary therapy

scientific article published on August 2007

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer

scientific article published on 4 November 2011

An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer ⬇️

scientific article published on November 5, 2010

Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?

scientific article published on 19 February 2008

Anti-angiogenesis agents in metastatic or recurrent cervical cancer

scientific article published on 27 October 2009

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

scientific article published on 17 June 2014

Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer

scientific article

Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews

scientific article published on 05 March 2014

Asbestos and ovarian cancer: examining the historical evidence

scientific article published on 09 October 2020

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.

scientific article

Assessment and Significance of Quality of Life in Women with Gynecologic Cancer ⬇️

scientific article published on August 1, 2010

Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials

scientific article

Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study

scientific article published on 03 July 2006

Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study

scientific article published in July 2004

Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study

scientific article published on 8 December 2011

Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design

scientific article published on 27 March 2018

Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey

scientific article published on 28 January 2017

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

scientific article

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).

scientific article published on 29 January 2015

Bevacizumab in the treatment of ovarian cancer

scientific article published on 01 October 2007

Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis

scientific article

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study

scientific article published on 25 July 2020

Bevacizumab toxicities and their management in ovarian cancer

scientific article published on 02 April 2010

Beyond platinum for metastatic and recurrent carcinoma of the cervix

scientific article published on 15 September 2009

Biologics in cervical cancer therapy

scientific article published in December 2010

Biosimilars: Extrapolating the evidence. A roundtable discussion

scientific article published in December 2015

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?

scientific article published on 7 September 2017

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study

scientific article published on 23 May 2020

COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies

scientific article published on 29 April 2020

Carcinogenic human papillomavirus infection

scientific article published in December 2016

Cervical cancer screening

scientific article published on 01 November 2004

Cervical cancer therapy: current, future and anti-angiogensis targeted treatment

scientific article published on July 2009

Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease

scientific article published on July 2008

Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease

scientific article published on July 2008

Changes in tumor blood flow as measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) may predict activity of single agent bevacizumab in recurrent epithelial ovarian (EOC) and primary peritoneal cancer (PPC) patients: an explora

scientific article published on 7 June 2012

Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds

scientific article published on December 2009

Chemotherapy in the management of cervical carcinoma.

scientific article

Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group

scientific article

Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology - Gynecologic Oncology Group Study 240 (NCT 00803062)

scientific article published on 26 August 2020

Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer

scientific article published on 12 June 2011

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

scientific article

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

scientific article

Clinical trials, adaptability and the COVID-19 pandemic

scientific article published on 08 December 2020

Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment

scientific article

Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study

scientific article

Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma

scientific article

Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma

scientific article published on 01 October 2004

Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study

scientific article

Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program

scientific article published in October 2007

Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma

scientific article published on 13 March 2020

Data on prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer: Post-hoc data analysis from the phase 3 randomized, open-label study comparing trabectedin and PLD versus PLD alone in patients with recurrent ovarian cancer

scientific article published on 20 March 2020

Desmoplastic stromal response as defined by positive α-smooth muscle actin staining is predictive of invasion in adenocarcinoma of the uterine cervix.

scientific article published in July 2012

Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer

scientific article published on 13 July 2015

Development of a platform for systemic antiangiogenesis therapy for advanced cervical cancer

scientific article

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.

scientific article published on 2 July 2015

Development of an in vitro chemo-radiation response assay for cervical carcinoma

scientific article published in November 2002

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients

scientific article published on 19 June 2019

Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumor

scientific article published on July 2011

Disparities in Vulvar Cancer Reported by the National Cancer Database: Influence of Sociodemographic Factors

scientific article published on 3 September 2015

Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group

scientific article published on 07 December 2010

Does the ALTS trial apply to the community-based practitioner?

scientific article published on 01 June 2003

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion ⬇️

scientific article published on September 15, 2003

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial

scientific article

Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study

scientific article published in January 2005

Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma

scientific article published on 12 August 2019

Evidence-based therapy for recurrent cervical cancer

scientific article published on 28 July 2014

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients

scientific article published on 5 May 2016

Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study

scientific article published on 22 September 2015

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer

scientific article published on 30 April 2012

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.

scientific article

Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.

scientific article

Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials

scientific article published on 3 September 2014

Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis

scientific article published on 14 May 2019

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

scientific article published on 19 June 2019

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

scientific article published on 18 August 2016

Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma

scientific article published in November 2004

Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial

scientific article published on 01 December 2020

Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study.

scientific article published in October 2005

Green tea catechins for treatment of external genital warts

scientific article

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma

scientific article

Gynecologic Oncology Research and Practice: a new journal to meet the needs of a growing field

scientific article published on 30 September 2014

Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer

scientific article

Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life.

scientific article published on 26 February 2016

Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.

scientific article

Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.

scientific article published on 23 January 2015

High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.

scientific article

Human papillomavirus infections

scientific article published on 01 January 2004

Human papillomavirus vaccine: a new chance to prevent cervical cancer.

scientific article published on January 2007

Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State

scientific article published on 01 October 2019

Impact of facility volume on therapy and survival for locally advanced cervical cancer

scientific article published on 12 December 2013

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

scientific article published on 28 November 2017

Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: follow-up of a Southwest Oncology Group and Gynecologic

scientific article published on 17 May 2009

Improved survival with bevacizumab in advanced cervical cancer

scientific article

In assessing surrogate clinical trial end points: drug safety is a requisite.

scientific article

In vitro chemoresponse in metachronous pairs of gyneclologic cancers

scientific article published on 06 December 2014

In vitro chemoresponse in metachronous pairs of ovarian cancers.

scientific article published in December 2014

Incidence and management of edema associated with trebananib (AMG 386).

scientific article published on 23 May 2013

Incorporation of bevacizumab in the primary treatment of ovarian cancer

scientific article published in December 2011

Incorporation of pazopanib in maintenance therapy of ovarian cancer

scientific article

Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy

scientific article published on 04 December 2019

Influence of serum and tissue micronutrient levels on the regression of untreated cervical intraepithelial neoplasia 2 and 3.

scientific article

Initial lessons learned in HPV vaccination

scientific article published on May 2008

Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy

scientific article

Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant?

scientific article published on 01 April 2007

Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model

scientific article published in October 2002

Latest research and treatment of advanced-stage epithelial ovarian cancer

scientific article published on 05 February 2013

Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?

scientific article published on 10 October 2019

Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study

scientific article

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).

scientific article published on 3 November 2014

Low-grade serous ovarian cancer: expert consensus report on the state of the science

scientific article published on 17 August 2023

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

scientific article published on 21 August 2020

Management of nausea and vomiting from poly(ADP-ribose) polymerase inhibitor therapy for advanced ovarian cancer

scientific article published on 21 September 2020

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

scientific article

Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy

scientific article

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

scientific article published on 15 August 2023

Moving beyond cytotoxic drug dosing in ovarian cancer

scientific article published on 29 November 2019

Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer.

scientific article

Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions

scientific article published on July 2007

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

scientific article published on 25 July 2020

Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG Oncology/Gynecologic Oncology Group study.

scientific article

New Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer

scientific article published on 26 May 2016

New developments in the treatment of invasive cervical cancer

scientific article

New strategies in advanced cervical cancer: from angiogenesis blockade to immunotherapy

scientific article published on 07 August 2014

Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial

scientific article published on 5 November 2013

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

scientific article published on 07 June 2019

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

scientific article

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

scientific article published on 28 September 2019

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 01 April 2019

Optimal treatment for platinum-sensitive recurrent ovarian cancer

scientific article published in September 2017

Ovarian Cancer: Current Treatment and Patient Management

scientific article

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper

scientific article

Ovarian cancer: relevant therapy, not timing, is paramount ⬇️

scientific article published on 01 October 2010

PARP Inhibitors in Ovarian Cancer. Reply

scientific article published on 01 April 2020

PARP inhibition as frontline therapy in ovarian cancer

scientific article published on 01 September 2020

PARP inhibition in recurrent ovarian cancer

scientific article published on 01 October 2020

PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy

Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer

scientific article published on 2 June 2016

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study

scientific article

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

scientific article published on 28 February 2020

Patient-reported outcomes in relapsed ovarian cancer: results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD alone

scientific article published on 2 July 2012

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience

scientific article published in August 2009

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer ⬇️

journal article from 'New England Journal of Medicine' published in 2021

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study

scientific article

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study

scientific article published on 05 July 2020

Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study

scientific article

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

scientific article

Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study

scientific article

Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer

scientific article published on 6 July 2010

Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group Study

scientific article published on 01 February 2007

Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria

scientific article

Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.

scientific article

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study

scientific article

Philip John DiSaia, MD: Available Light & The Origin of Storms

scientific article published on 30 April 2020

Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid

scientific article

Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma

scientific article published on 06 April 2017

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer ⬇️

scientific article published on September 25, 2010

Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial

scientific article

Pretreatment CA-125 and risk of relapse in advanced ovarian cancer

scientific article published on 01 March 2006

Primary invasive vaginal cancer in the setting of the Mayer-Rokitansky-Kuster-Hauser syndrome

scientific article

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study

scientific article

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study

scientific article

Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.

scientific article published in February 2003

Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study

scientific article

Progress in record numbers of approved therapies for gynecologic cancers: The lack of upfront approval for newly diagnosed cases

scientific article

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial

scientific article

Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study.

scientific article

Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: A Southwest Oncology Group Study ⬇️

scientific article published on September 16, 2010

Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

scientific article published on 30 September 2014

Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial

scientific article

Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study

scientific article published in February 2012

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.

scientific article published on 23 May 2005

Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study.

scientific article

Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer

scientific article published on June 2012

Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy

scientific article published in July 2004

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

scientific article published on 23 May 2016

Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study

scientific article published on 17 October 2005

Real world experience of poly (ADP-ribose) polymerase inhibitor use in a community oncology practice

scientific article published on 15 August 2020

Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group

scientific article published on April 2009

Recent advances in human papillomavirus vaccines

scientific article published on November 2006

Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial

scientific article

Reducing the burden of glandular carcinomas of the uterine cervix

scientific article published in December 2007

Relationship between social support, quality of life, and Th2 cytokines in a biobehavioral cancer survivorship trial

scientific article published on 05 January 2019

Reply to F.M. Muggia

scientific article

Reply to Farolfi et al and Haines et al

scientific article published on 07 November 2019

Reply to W.A.A. Tjalma and J.S. Grossman

scientific article published on 9 February 2015

Response to "surgical management of cervical cancer by laparoscopy or laparotomy"

Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial

scientific article

Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study

scientific article

Role of pegylated liposomal doxorubicin in ovarian cancer

scientific article

SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm

scientific article

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

scientific article published on 14 April 2016

Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer

scientific article published on 21 June 2006

Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance

scientific article published on 26 September 2020

Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.

scientific article published on February 2014

Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.

scientific article published on 4 February 2016

State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer

scientific article published on 09 July 2015

Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected].

scientific article

Supportive care for women with gynecologic cancers

scientific article published on February 2008

Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study

scientific article published on 27 November 2009

Survival data from a phase II, open-label study of pazopanib or lapatinib monotherapy in patients with advanced and recurrent cervical cancer

scientific article published on 14 November 2011

Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm

scientific article published on 23 August 2018

Systemic therapy for recurrent endometrial cancer: a review of North American trials

scientific article published on July 2009

The American Society of Clinical Oncology 2016 annual meeting: A review and summary of selected abstracts

scientific article published on 4 November 2016

The American Society of Clinical Oncology 2017 Annual Meeting: A review and summary of selected abstracts

scientific article

The American Society of Clinical Oncology 2018 annual meeting: A review and summary of selected abstracts

scientific article published on 31 August 2018

The American Society of Clinical Oncology 2019 annual meeting: A review and summary of selected abstracts

scientific article published on 12 July 2019

The American Society of Clinical Oncology 50th Annual Meeting 2014: an overview and summary of selected abstracts

scientific article

The American Society of Clinical Oncology 51st Annual Meeting 2015: An overview and summary of selected abstracts

scientific article published on 27 June 2015

The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian Cancer

scientific article published on 01 January 2019

The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials

scientific article

The development and use of vascular targeted therapy in ovarian cancer

scientific article published on 23 February 2017

The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination

scientific article published on 01 October 2007

The impact of cervical cancer on quality of life: a personal account.

scientific article published in May 2008

The new era of cervical cancer prevention: HPV vaccination

scientific article published on 01 May 2008

The pediatrician's role in preventing cervical cancer

scientific article published on September 2008

The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study

scientific article published on 28 November 2009

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma

scientific article published on 31 October 2023

The rationale for the use of non-platinum chemotherapy doublets for metastatic and recurrent cervical carcinoma.

scientific article published in February 2010

The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative

scientific article

The role of immune checkpoint inhibition in the treatment of ovarian cancer

scientific article

The spectrum and clinical sequelae of human papillomavirus infection

scientific article

The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment.

scientific article published on 5 May 2015

Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.

scientific article

Topotecan in the management of cervical cancer

scientific article published on February 2007

Trabectedin as a chemotherapy option for patients with BRCA deficiency

scientific article

Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancer

scientific article

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.

scientific article published in June 2010

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis

scientific article published on 26 April 2012

Treatment of metastatic cervical cancer: future directions involving targeted agents

scientific article published on 09 August 2012

Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation

scientific article

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

scientific article published on 07 May 2019

Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years

scientific article published on 27 June 2018

Updates on drug discovery in ovarian cancer

scientific article published on 30 September 2014

Vaccines against human papillomavirus and cervical cancer: promises and challenges

scientific article

Validation of PROMIS emotional distress short form scales for cervical cancer

scientific article published on 02 August 2018

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

scientific article published on February 2016

What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?

scientific article published on 01 April 2007

What is the standard therapy for bulky stage IB cervical cancer?

scientific article published on 01 April 2009

When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer

scientific article published on 01 April 2009

Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials

scientific article

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

scientific article published on 21 March 2017

Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America?

scientific article published in August 2006

Paulina is supported by:

About Paulina

Help